Stock of the Day

December 16, 2025

Thermo Fisher Scientific (TMO)

$532.17
-$11.02 (-2.0%)
Market Cap: $201.86B

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Bull Case

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

  • The current stock price is around $462, reflecting a strong market position and investor confidence in the company's growth potential.
  • Thermo Fisher Scientific Inc. has demonstrated a solid return on equity of 16.86%, indicating effective management and profitability relative to shareholder equity.
  • The company has a net margin of 15.15%, showcasing its ability to convert revenue into actual profit, which is a positive sign for investors looking for stable returns.
  • Recent quarterly revenue growth of 6.2% year-over-year suggests that the company is expanding its market share and maintaining strong demand for its products and services.
  • With a dividend payout ratio of 10.34%, Thermo Fisher Scientific Inc. is returning a portion of its profits to shareholders, which can be attractive for income-focused investors.

Thermo Fisher Scientific Bear Case

Investors should be bearish about investing in Thermo Fisher Scientific Inc. for these reasons:

  • Insider ownership is relatively low at 0.33%, which may raise concerns about alignment between management and shareholder interests.
  • Recent insider selling, including a COO selling 400 shares, could signal a lack of confidence in the company's short-term performance or future prospects.
  • The annualized dividend yield of 0.4% is relatively low, which may not be appealing for investors seeking higher income from their investments.
  • While the company has set its FY 2026 guidance at 24.640-25.120 EPS, any failure to meet these expectations could negatively impact stock performance and investor sentiment.
  • Market volatility and economic uncertainties could pose risks to the company's growth trajectory and overall financial stability.

Institutions Love These 3 Companies, Should You As Well?

Written By Nathan Reiff on 11/19/2025

Intuit logo on smartphone, with rising stock chart in background.

A common strategy among retail investors is to mirror the investment moves of successful firms and market leaders. Poring over the Form 13-F results of gurus like Warren Buffett can reveal valuable insights, albeit on a delayed schedule. For more timely data, everyday investors might instead look to institutional ownership to gain information about where seasoned investors are placing their bets.

Institutional ownership of 80% or more typically suggests that a company has passed rigorous evaluation processes and appeals to analysts focused on fundamentals and long-term potential. Additionally, high institutional ownership can boost liquidity and signal that a stock is likely to remain stable or even ascend in price. The three stocks below all have significant institutional ownership as well as broad bullishness from analysts, signaling their potential for growth in the future.

OpenAI Partnership, Strong Earnings Drives Institutional Interest in Thermo Fisher

The products that Thermo Fisher Scientific (NYSE: TMO) provides—including diagnostic products and tools, reagents, and related services—make it possible for a huge network of clients in the sciences to conduct their work.

The firm is fresh off a strong quarter despite the tumult facing Thermo Fisher's academic clients.

Thermo Fisher's recent earnings report included both top- and bottom-line wins as it reported 10% year-over-year (YOY) adjusted earnings per share (EPS) improvement, driven by growth in its life sciences solutions and specialty diagnostics divisions.

Thermo Fisher's revenue came in above $11.1 billion, prompting executives to upgrade full-year guidance. Key to this achievement is its high-momentum product development, accelerated by its adoption of AI, underscored by its recent partnership with OpenAI.

The company may primarily appeal to buy-and-hold investors due to the near-term challenges it faces, including an expected decline in its China business, lingering uncertainty in the academic sector over federal funding, and shifting tariffs.

On the other hand, repatriation of science firms may help to drive domestic growth. This could be why investment institutions own more than 89% of all outstanding TMO shares, and why about 80% of analysts call the company a Buy. 

Linde Leads in Industrial Gases Thanks to Strong Backlog and Hydrogen Potential

Sector leader Linde (NASDAQ: LIN) dominates the industrial gases space and is well-positioned to benefit from the continued adoption of clean hydrogen energy around the world.

Indeed, the company already has projected EPS gains for future quarters as a result of its massive, $10-billion backlog.

Last quarter, Linde posted a 7% YOY EPS gain and generated $1.7 billion in free cash flow, with operating cash flow up 8%.

Despite the fact that some analysts have recently moderated their price targets for Linde—likely on the assumption that the shares have already priced in some of the anticipated near-term gains—the consensus price target of more than $508 still represents almost 22% in potential upside.

Eight out of 10 analysts identify LIN shares as a Buy, and nearly 83% of shares are owned by institutions.

Financial Software Firm to Get a Boost From Tax Changes, Subscriptions

Intuit Inc. (NASDAQ: INTU), maker of financial software products including QuickBooks and TurboTax, benefits from a strong recurring revenue profile, thanks to its subscription services.

To maintain its growth, the firm will likely need to continue boosting its subscriber base through newer services like TurboTax live.

Another boost is likely to come from recent changes to the IRS's Direct File program, which will not be available in 2026, potentially pushing more users to products like TurboTax.

Institutions seem to think the company can deliver, with close to 84% of shares owned by institutional investors. This is no surprise given that 22 of 27 analysts are optimistic about Intuit's future performance—as evidenced by a consensus price target suggesting upside of 23% and one-year earnings growth just under 14%.

On top of that, INTU shares have had a middling performance this year, climbing by under 4% YTD, which may make them primed for gains if the company posts positive subscriber updates.

Recent News